Biomarker use in predicting transcranial direct-current stimulation (tDCS) response: a systematic scoping review
Abstract
Introduction: Trans-cranial Direct Current Stimulation (tDCS) is a non-invasive neuromodulation technique with increasing evidence of efficacy in treating neuropsychiatric conditions. There is a need for biomarkers to predict and monitor tDCS efficacy. We aimed to conduct a systematic scoping review to assess the evidence regarding the ability of biomarkers to predict response to tDCS and identify promising candidate biomarkers in neuropsychiatric patient populations.
Methods: Comprehensive searches were conducted in the MEDLINE and EMBASE databases on 24/09/2023. Articles were screened at the title and abstract level and then at full text, and inclusion/exclusion criteria applies. Data was extracted and the quality of the studies assessed with the JADAD, MINORS and Ottawa rating scales. 154 including 154 studies in the review. Disorders studied weredivided into 10 categories, Stroke/Aphasia, Psychotic Disorders, Affective Disorders, Neurocognitive Disorders, Pain Disorders, Addiction Disorders, Disorders of Consciousness, Multiple Sclerosis, Neurodevelopmental Disorders and Traumatic Brain Injury. Biomarkers with positive results in at least 2 studies in each group were identified.
Results: The most common biomarker across groups was functional connectivity, appearing in 7 of 10 groups. This was followed by EEG features and Cortical Activation. The biomarkers with most evidence have plausible mechanisms of action and have been previously proposed as candidate biomarkers in…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.